Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AC Immune SA (ACIU)
NASDAQ:ACIU
AC Immune SA (ACIU) Stock Price & Analysis
399 Followers
ACIU Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.90 - $5.14
Previous Close$2.35
Volume138.04K
Average Volume (3M)185.44K
Market Cap
$233.11M
Enterprise Value$150.47M
Total Cash (Recent Filing)CHF78.49M
Total Debt (Recent Filing)CHF3.50M
Price to Earnings (P/E)-3.3
Beta1.02
Next Earnings
Aug 01, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding99,197,829
10 Day Avg. Volume163,210
30 Day Avg. Volume185,439
Standard Deviation0.17
R-Squared0.11
Alpha-0.00768
Financial Highlights & Ratios
Price to Book (P/B)2.14
Price to Sales (P/S)15.75
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$12.50Price Target Upside431.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
AC Immune SA News
Ownership Overview
0.00%
Insiders
1.21% Mutual Funds
0.73% Other Institutional Investors
98.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ACIU FAQ
What was AC Immune SA’s price range in the past 12 months?
AC Immune SA lowest stock price was $1.90 and its highest was $5.14 in the past 12 months.
What is AC Immune SA’s market cap?
Currently, no data Available
When is AC Immune SA’s upcoming earnings report date?
AC Immune SA’s upcoming earnings report date is Aug 01, 2024 which is in 83 days.
How were AC Immune SA’s earnings last quarter?
Currently, no data Available
Is AC Immune SA overvalued?
According to Wall Street analysts AC Immune SA’s price is currently Undervalued.
Does AC Immune SA pay dividends?
AC Immune SA does not currently pay dividends.
What is AC Immune SA’s EPS estimate?
AC Immune SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AC Immune SA have?
AC Immune SA has 99,197,830 shares outstanding.
What happened to AC Immune SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AC Immune SA?
Among the largest hedge funds holding AC Immune SA’s share is Platinum Investment Management. It holds AC Immune SA’s shares valued at 8M.
---
AC Immune SA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.50 (431.91% Upside)
$12.50 (431.91% Upside)
Blogger Sentiment
Bullish
ACIU Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 193.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.37%
12-Months-Change
Fundamentals
Return on Equity
-32.20%
Trailing 12-Months
Asset Growth
8.08%
Trailing 12-Months
Company Description
AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
---
ACIU Stock 12 Month Forecast
Average Price Target
$12.50
▲(431.91% Upside)
Technical Analysis
Best Analysts Covering ACIU
1 Year
1 Year Success Rate
3/20 ratings generated profit
1 Year Average Return
-20.09%
reiterated a buy rating 2 months ago
Copying Marc Goodman's trades and holding each position for 1 Year would result in 15.00% of your transactions generating a profit, with an average return of -20.09% per trade.
---